GARY WASHINGTON: Open Payments
NPI 1548643307 · AUBURN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 19 payments from 10 companies in 2025. Trend: 2023 $176 · 2024 $1,119 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 5 | $258 |
| Galderma Laboratories, L.P. | 1 | $82 |
| Novo Nordisk Inc | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| MILLICENT US INC | 2 | $40 |
| Becton, Dickinson and Company | 1 | $30 |
| Evofem Biosciences, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $4 |
Products named: DAXXIFY, Wegovy, Kyleena, ARISTA, Phexxi, FEMRING, LILETTA, SLYND.
Industry payments across GA — which companies pay providers there.
